Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)

A Correction to this article was published on 09 April 2020

This article has been updated

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative procedure in patients with Shwachman–Diamond syndrome (SDS) with bone marrow abnormalities. The results of 74 patients with SDS (6 acute myeloid leukemia, 7 myelodysplastic syndrome, and 61 bone marrow failure) treated with HSCT between 1988 and 2016 are reported. The donor source was: 24% sibling, 8% parent, and 68% unrelated donor. The stem cell source was: 70% bone marrow, 19% peripheral blood stem cells, and 11% cord blood. The conditioning regimen was myeloablative in 54% and reduced intensity in 46%. Neutrophil engraftment was achieved in 84% of patients after a median time of 17.5 days. Graft failure occurred in 15% of HSCTs. Grades I–IV acute and chronic GVHD were observed in 55% and 20% of patients, respectively. After a median follow-up of 7.3 years (95% CI 4.8–10.2), 28 patients died for progression/relapse (7) or toxicity (21). The 5-year overall survival and nonrelapse mortality were 63.3% (95% CI 50.8–73.4) and 19.8% (95% CI 10.8–30.8), respectively. In conclusion, this is the largest series so far reported and confirms that HSCT is a suitable option for patients with SDS. Further efforts are needed to lower transplant-related toxicity and reduce graft failure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Cumulative incidence of neutrophil engraftment in the study patients.
Fig. 2: Overall survival of 74 patients with SDS who received stem cell transplant.
Fig. 3: Overall survival according to the indication to hematopoietic stem cell transplant.
Fig. 4: Nonrelapse mortality curve in study patients.

Similar content being viewed by others

Change history

References

  1. Goobie S, Popovic M, Morrison J, Ellis L, Ginzberg H, Boocock GR, et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet. 2001;68:1048–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Boocock GR, Morrison JA, Popovic M, Richards N, Ellis N, Durie PR, et al. Mutations in SBDS are associated with Shwachman–Diamond syndrome. Nat Genet. 2003;33:97–101.

    CAS  PubMed  Google Scholar 

  3. Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011;1242:40–55.

    PubMed  Google Scholar 

  4. Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C, et al. Haematopoietic stem cell transplantation for Shwachman– Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol. 2005;131:231–6.

    PubMed  Google Scholar 

  5. Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B, et al. Hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transpl. 2005;36:787–92.

    CAS  Google Scholar 

  6. Isaev AA, Deev RV, Kuliev, Plaxa iL, Stancheva NV, Borovkova AS, et al. First experience of hematopoietic stem cell transplantation treatment of Shwachman–Diamond syndrome using unaffected HLA–matched sibling donor produced through preimplantation HLA typing. Bone Marrow Transpl. 2017;52:1249–52.

    CAS  Google Scholar 

  7. Barber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

    Google Scholar 

  8. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51.

    CAS  PubMed  Google Scholar 

  9. Carreras E, Dufour C, Mohty M, Kroger N. The EBMT Handbook. Hematopoietic stem cell transplantation and cellular therapy. Springer Open ebook 2019. https://doi.org/10.1007/978-3-030-02278-5.

  10. Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone Marrow Transpl. 2008;41(Suppl 2):S58–64. EBMT Paediatric Working Party.

    CAS  Google Scholar 

  11. Dignan FL, Amrolia P, Clark A, Comish J, Jackson G, Mahendra P, et al. Diagnosis and management of chronic graft-versus-host disease. Br J Haematol. 2012;158:46–61.

    CAS  PubMed  Google Scholar 

  12. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628–33.

    PubMed  PubMed Central  Google Scholar 

  13. Tsai PH, Sahdev I, Herry A, Lipton JM. Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman-Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol. 1990;12:472–6.

    CAS  PubMed  Google Scholar 

  14. Barrios N, Kirkpatrick D, Regueira O, Wuttke B, McNeil J, Humbert J. Bone marrow transplant in Shwachman Diamond syndrome. Br J Haematol. 1999;79:337–8.

    Google Scholar 

  15. Seymour JF, Escudier SM. Acute leukemia complicating bone marrow hypoplasia in an adult with Shwachman’s syndrome. Leuk Lymphoma. 1993;12:131–5.

    CAS  PubMed  Google Scholar 

  16. Smith OP, Chan MY, Evans J, Veys P. Shwachman-Diamond syndrome and matched unrelated donor BMT. Bone Marrow Transpl. 1995;16:717–8.

    CAS  Google Scholar 

  17. Smith OP, Hann IM, Chessells JM, Reeves BR, Milla P. Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol. 1996;94:279–84.

    CAS  PubMed  Google Scholar 

  18. Bunin N, Leahey A, Dunn S. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation. Transplantation. 1996;61:664–6.

    CAS  PubMed  Google Scholar 

  19. Arseniev L, Diedrich H, Link H. Allogeneic bone marrow transplantation in a patient with Shwachman-Diamond syndrome. Ann Hematol. 1996;72:83–4.

    CAS  PubMed  Google Scholar 

  20. Dokal I, Rule S, Chen F, Potter M, Goldman J. Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman-Diamond syndrome. Br J Haematol. 1997;99:171–3.

    CAS  PubMed  Google Scholar 

  21. Davies SM, Wagner JE, DeFor T, Blazar BR, Katsanis E, Kersey JH, et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol. 1997;96:749–56.

    CAS  PubMed  Google Scholar 

  22. Okcu F, Roberts WM, Chan KW. Bone marrow transplantation in Shwachman–Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplant. 1998;21:849–51.

    CAS  PubMed  Google Scholar 

  23. Miano M, Porta F, Locatelli F, Miniero R, La Nasa G, Di Bartolomeo P, et al. Unrelated donor marrow transplantation for inborn errors. Bone Marrow Transpl. 1998;21:S37–41.

    Google Scholar 

  24. Faber J, Lauener R, Wick F, Betts D, Filgueira L, Seger RA, et al. Shwachman-Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis. Eur J Pediatr. 1999;158:995–1000.

    CAS  PubMed  Google Scholar 

  25. Cipolli M, D’Orazio C, Delmarco A, Marchesini C, Miano A, Mastella G. Shwachman’s syndrome: pathomorphosis and long-term outcome. J Pediatr Gastroenterol Nutr. 1999;29:265–72.

    CAS  PubMed  Google Scholar 

  26. Cesaro S, Guariso G, Calore E, Gazzola MV, Destro R, Varotto S, et al. Successful unrelated bone marrow transplantation for Shwachman-Diamond syndrome. Bone Marrow Transpl. 2001;27:97–9.

    CAS  Google Scholar 

  27. Fleitz J, Rumelhart S, Goldman F, Ambruso D, Sokol RJ, Pacini D, et al. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome. Bone Marrow Transpl. 2002;29:75–9.

    CAS  Google Scholar 

  28. Hsu JW, Vogelsang G, Jones RJ, Brodsky RA. Bone marrow transplantation in Shwachman-Diamond syndrome. Bone Marrow Transpl. 2002;30:255–8.

    CAS  Google Scholar 

  29. Park SY, Chae MB, Kwack YG, Lee MH, Kim I, Kim YS, et al. Allogeneic bone marrow transplantation in Shwachman-Diamond syndrome with malignant myeloid transformation. A case report. Korean J Intern Med. 2002;17:204–6.

    PubMed  PubMed Central  Google Scholar 

  30. Cunningham J, Sales M, Pearce A, Howard J, Stallings R, Telford N, et al. Does isochromosome 7q mandate bone marrow transplant in children with Shwachman–Diamond syndrome? Br J Haematol. 2002;119:1062–9.

    PubMed  Google Scholar 

  31. Mitsui T, Kawakami T, Sendo D, Katsuura M, Shimizu Y, Hayasaka K. Successful unrelated donor bone marrow transplantation for Shwachman-Diamond syndrome with leukemia. Int J Hematol. 2004;79:189–92.

    PubMed  Google Scholar 

  32. Vibhakar R, Radhi M, Rumelhart S, Tatman T, Goldman F. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transpl. 2005;36:855–61.

    CAS  Google Scholar 

  33. Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K, et al. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman–Diamond syndrome. Bone Marrow Transpl. 2007;39:143–7.

    CAS  Google Scholar 

  34. Bhatla D, Davies SM, Shenoy S, Harris RE, Crockett M, Shoultz L, et al. Reduced intensity conditioning is safe and effective for transplantation of patients with Shwachman Diamond syndrome. Bone Marrow Transpl. 2008;42:159–65.

    CAS  Google Scholar 

  35. Linden T, Ehlert K, Niemeyer CM, Fleischhack G, Jürgens H, Rossig C. Molecular diagnosis of Shwachman-Diamond syndrome in a child with incomplete clinical disease phenotype. Pediatr Blood Cancer. 2010;55:177–9.

    PubMed  Google Scholar 

  36. Bizzetto R, Bonfim C, Rocha V, Sociè G, Locatelli F, Chan K, et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica. 2011;96:134–41.

    PubMed  Google Scholar 

  37. Keogh SJ, McKee S, Smithson SF, Grier D, Steward CG. Shwachman-Diamond syndrome: a complex case demonstrating the potential for misdiagnosis as asphyxiating thoracic dystrophy (Jeune syndrome). BMC Pediatr. 2012;12:48.

    PubMed  PubMed Central  Google Scholar 

  38. Bertaina A, Merli P, Rutella S, Pagliara D, Bernardo ME, Masetti R, et al. HLA-haploidentical stem cell transplantation after removal of αβ+T and B cells in children with nonmalignant disorders. Blood. 2014;124:822–6.

    CAS  PubMed  Google Scholar 

  39. Myers KC, Rose SR, Rutter MM, Meha PA, Khoury JC, Cole T, et al. Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome genemutations and Shwachman-Diamond syndrome. J Pediatr. 2013;162:1235–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Myers KC, Bolyard AA, Otto B, Wong TE, Jones AT, Harris RE, et al. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North-American Shwachman-Diamond syndrome registry. J Pediatr. 2014;164:866–70.

    PubMed  Google Scholar 

  41. Delaporta P, Sofocleous C, Economou M, Makis A, Kostaridou S, Kattamis A. The Greek Registry of Shwachman-Diamond syndrome: molecular and clinical data. Pediatr Blood Cancer. 2017;64:1–4.

    Google Scholar 

  42. Burroughs LM, Shimamura A, Talano JA, Domm JA, Baker KK, Delaney C, et al. Allogeneic hematopoietic cell transplantation using treosulfan-based conditioning for treatment of marrow failure disorders. Biol Blood Marrow Transplant. 2017;23:1669–77.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Shimosato Y, Tanoshima R, Tsujimoto SI, Takeuchi M, Sakari K, Kajiwara R, et al. Association of isochromosome (7)(q10) in Shwachman-Diamond syndrome with the severity of cytopenia. Clin Case Rep. 2018;6:125–8.

    PubMed  Google Scholar 

  44. Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahiaoui N, et al. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica. 2012;97:1312–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med. 2017;376:536–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Xia J, Miller CA, Baty J, Ramesh A, Jotte MRM, Fulton RS, et al. Somatic mutations and clonal hematopoiesis in congenital neutropenia. Blood. 2018;131:408–16.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Cremers EM, Van Biezen A, de Wreede LC, Scholten M, Vitek A, Finke J, et al. Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT. Ann Hematol. 2016;95:1971–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Bacigalupo A, Socie’ G, Lanino E, Prete A, Locatelli F, Cesaro S, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica. 2010;95:976–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Bardelli D, Dander E, Bugarin C, Cappuzzello C, Pievani A, Fazio G, et al. Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis. Br J Haematol. 2018;182:114–24.

    CAS  PubMed  Google Scholar 

  50. Ciurea SO, Al Malki MM, Kongtim P, Fuchs EJ, Luznik L, Huang XJ, et al. The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone Marrow Transpl. 2019. https://doi.org/10.1038/s41409-019-0499-z.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Mr Rodney Seddon for reviewing the English style of manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone Cesaro.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Appendix

Appendix

List of EBMT contributing centers. Center indentifying code (CIC)

CIC 295 Hannover (Christian Kratz, 4), CIC 285 Padova (Marta Pillon, 4), CIC 160 Paris Necker (Benedicte Neven, 4), CIC 301 Marseille (Gerard Michel, 3), CIC 386 Bristol (Stephen Robinson, 3), CIC 424 Montréal (Henrique Bittencourt, 3), CIC 707 Glasgow (Brenda E. Gibson, 3), CIC 234 Brussels (Xavier Poiré, 2),CIC 203 Leiden (Stijn Halkes, 2), CIC 274 Genova (Edoardo Lanino, 2), CIC 207 Paris St. Louis (Regis Peffault de Latour, 2), CIC 422 Barcelona Vall d’Hebron (Cristina Diaz de Heredia, 2), CIC 521 Manchester (Robert Wynn, 2), CIC 796 Rome (Franco Locatelli, 2), CIC 524 Heidelberg (Johann Greil, 2), CIC 243 London (Paul Veys, 2), CIC 775 Paris Saint Antoine (Mohammad Mohty, 1), CIC 246 Rotterdam (Jan Cornelissen, 1), CIC 457 Istanbul (Gülyüz Öztürk, 1), CIC 535 Tübingen (Rupert Handgretinger,1), CIC 539 London (Mickey Koh, 1), CIC 631 Paris Robert Debre (Jean-Hughes Dalle, 1), CIC 751 Athens (Vassiliki Kitra-Rossou, 1), CIC 806 Lyon (Yves Bertrand, 1). CIC 209 Leuven (Anne Uyttebroek,1), CIC 212 Stockholm (Per Ljungman,1), CIC 253 Nantes (Patrice Chevalier, 1), CIC 261 Geneva (Marc Ansari, 1), CIC 260 Barcelona Santa Creu i Sant Pau (Isabel Badell, 1), CIC 208 Zürich (Tayfun Güngör, 1), CIC 501 Liverpool (Salim Rahuman, 1), CIC 513 Munich (Johanna Tischer, 1), CIC 623 Verona (Cristina Tecchio, 1), CIC 717 Nottingham (Nigel Russel, 1), CIC 817 Wroclaw (Alicia Chybicka, 1), CIC 764, Bydgoszcz, (Jan Styczynski, 1), CIC 824 Budapest (Krisztian Kallay, 1), CIC 774 Dublin (Owen Smith, 1), CIC 775 Petach-Tikva (Jerry Stein, 1), CIC 725 St. Petersburg (Boris Afanasyev,1), CIC 676 Nancy (Cécile Pochon, 1), CIC 795 Pisa (Maria Cristina Menconi, 1).

Collaborators

CIC 160 Paris Necker (Benedicte Neven, 4), CIC 301 Marseille (Gerard Michel, 3), CIC 386 Bristol (Stephen Robinson, 3), CIC 424 Montréal (Henrique Bittencourt, 3), CIC 707 Glasgow (Brenda E. Gibson, 3), CIC 234 Brussels (Xavier Poiré, 2), CIC 775 Paris Saint Antoine (Mohammad Mohty, 1), CIC 246 Rotterdam (Jan Cornelissen, 1), CIC 457 Istanbul (Gülyüz Öztürk, 1), CIC 535 Tübingen (Rupert Handgretinger,1), CIC 539 London (Mickey Koh, 1), CIC 631 Paris Robert Debre (Jean-Hughes Dalle, 1), CIC 751 Athens (Vassiliki Kitra-Rossou, 1), CIC 806 Lyon (Yves Bertrand, 1).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cesaro, S., Pillon, M., Sauer, M. et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT). Bone Marrow Transplant 55, 1796–1809 (2020). https://doi.org/10.1038/s41409-020-0863-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-020-0863-z

This article is cited by

Search

Quick links